Supernus Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Maryland, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
9715 Key West Ave, Rockville, Maryland, ...Phone Number
(301) 838-2500Website
www.supernus.comRevenue
$830.4 MillionStock Symbol
SUPNIndustry
About Supernus Pharmaceuticals
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system (CNS) diseases. Its portfolio includes treatments for epilepsy, ADHD, Parkinson’s disease, migraine, and other neurological disorders. The company combines internal research with strategic acquisitions to deliver medicines that address unmet patient needs while advancing a pipeline of novel CNS therapies.Explore more
Supernus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Supernus Pharmaceuticals
Compare insights from companies similar to Supernus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Supernus Pharmaceuticals Tech Stack
A closer look at the technologies used by Supernus Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Supernus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system (CNS) diseases. Its portfolio includes treatments for epilepsy, ADHD, Parkinson’s disease, migraine, and other neurological disorders. The company combines internal research with strategic acquisitions to... Read More
